(Q34412884)

English

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder

scientific article

Statements

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit